rs114115159
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_004517.4(ILK):c.65A>G(p.Asn22Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,611,672 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N22D) has been classified as Uncertain significance.
Frequency
Consequence
NM_004517.4 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ILK | NM_004517.4 | c.65A>G | p.Asn22Ser | missense_variant | Exon 2 of 13 | ENST00000299421.9 | NP_004508.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ILK | ENST00000299421.9 | c.65A>G | p.Asn22Ser | missense_variant | Exon 2 of 13 | 1 | NM_004517.4 | ENSP00000299421.4 |
Frequencies
GnomAD3 genomes AF: 0.000808 AC: 123AN: 152216Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00115 AC: 281AN: 243902 AF XY: 0.00117 show subpopulations
GnomAD4 exome AF: 0.00121 AC: 1766AN: 1459338Hom.: 3 Cov.: 30 AF XY: 0.00119 AC XY: 867AN XY: 725732 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000807 AC: 123AN: 152334Hom.: 1 Cov.: 32 AF XY: 0.000698 AC XY: 52AN XY: 74506 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:5
- -
- -
- -
- -
- -
not specified Uncertain:1Benign:1
p.Asn22Ser in exon 1 of ILK: This variant is not expected to have clinical signi ficance because it has been identified in 0.3% (151/47102) of European chromosom es by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; db SNP rs114115159). -
Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. ILK p.Asn22Ser Given lack of case data and the presence in the general population, we consider this variant a variant of uncertain significance. The variant has not been reported in association with disease. In silico analysis is inconsistent. The variant was reported online in 158 of 42181 individuals in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), which currently includes variant calls on ~64,000 individuals of European, African, Latino and Asian descent (as of June 11th, 2015). The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. -
Cardiomyopathy Benign:1
- -
Primary familial hypertrophic cardiomyopathy Benign:1
- -
ILK-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at